Master Neuroscience
for USMLE Step 1

What the USMLE Step 1 Tests in Neuroscience

Neuroscience on USMLE Step 1 tests the ability to localise lesions within the neuraxis using neuroanatomy, interpret reflex arcs and cranial nerve signs, and apply knowledge of neuropharmacology to conditions such as Parkinson's disease, epilepsy, and migraine. Candidates must identify stroke syndromes (e.g., lateral medullary syndrome, anterior spinal artery syndrome) by correlating vascular territories with deficits. They must recall diagnostic criteria (e.g., McDonald criteria for multiple sclerosis), first-line treatments (e.g., levetiracetam for focal seizures, sumatriptan for acute migraine), and interpret CSF findings (e.g., oligoclonal bands, elevated protein). Emphasis is on clinical reasoning: given a vignette with motor, sensory, or autonomic findings, select the lesion site, causative drug, or management step. Neuroimaging (CT, MRI) patterns and EEG correlates are also tested.

High-Yield Concepts

• Corticospinal Tract Lesions: Upper motor neuron (UMN) lesion causes spasticity, hyperreflexia, Babinski sign, and clonus; lower motor neuron (LMN) lesion causes flaccidity, hyporeflexia, fasciculations, and atrophy. In the internal capsule, a lacunar infarct produces contralateral hemiparesis sparing the face (if posterior limb) or including face (if genu).
• Parkinson's Disease Pharmacotherapy: First-line symptomatic treatment is levodopa/carbidopa. Dopamine agonists (pramipexole, ropinirole) are used in younger patients or as adjuncts. MAO-B inhibitors (selegiline, rasagiline) provide mild benefit. Anticholinergics (benztropine) help tremor. Avoid typical antipsychotics (haloperidol) due to dopamine blockade worsening symptoms.
• Multiple Sclerosis Diagnosis and Management: McDonald criteria require dissemination in space and time on MRI (T2 hyperintensities, gadolinium-enhancing lesions) plus clinical episodes. CSF shows oligoclonal bands and elevated IgG index. First-line disease-modifying therapy: interferon beta or glatiramer acetate. Acute relapses treated with IV methylprednisolone 1 g daily for 3–5 days.
• Stroke Syndromes by Vascular Territory: Middle cerebral artery (MCA) occlusion: contralateral hemiparesis (face > arm > leg), hemisensory loss, homonymous hemianopia, global aphasia (dominant hemisphere). Anterior cerebral artery (ACA): contralateral leg > arm weakness, urinary incontinence, abulia. Posterior cerebral artery (PCA): contralateral homonymous hemianopia with macular sparing, visual agnosia.
• Epilepsy Classification and First-Line Drugs: Focal seizures: first-line levetiracetam or lamotrigine. Generalised tonic-clonic: valproate or lamotrigine. Absence seizures: ethosuximide. Status epilepticus: IV lorazepam 0.1 mg/kg, then fosphenytoin 20 mg/kg PE. Avoid carbamazepine in absence and myoclonic seizures (may worsen).
• Cranial Nerve Lesions and Localisation: Third nerve palsy (CN III): ptosis, mydriasis, eye down-and-out. Pupil-sparing suggests ischaemic (microvascular) cause (e.g., diabetes); pupil-involved suggests compressive (e.g., posterior communicating artery aneurysm). Sixth nerve palsy (CN VI): medial strabismus, inability to abduct; false localising sign due to increased ICP.
• Migraine Acute and Prophylactic Treatment: Acute: triptans (sumatriptan 50–100 mg oral or 6 mg SC) within 1 hour of onset; NSAIDs (ibuprofen 400–600 mg) or antiemetics (metoclopramide 10 mg). Prophylaxis: propranolol 40–160 mg daily, amitriptyline 10–50 mg, topiramate 50–100 mg, or valproate. Avoid ergotamine in pregnancy and cardiovascular disease.
• Spinal Cord Lesion Patterns: Brown-Séquard syndrome (hemisection): ipsilateral UMN weakness and loss of vibration/proprioception below lesion, contralateral loss of pain/temperature 2–3 segments below. Anterior cord syndrome (anterior spinal artery occlusion): bilateral loss of motor and pain/temperature, preserved dorsal columns. Central cord syndrome (syringomyelia): bilateral loss of pain/temperature in cape distribution, preserved motor and dorsal columns.

Common Traps in Neuroscience Questions

• Confusing UMN and LMN signs: remember UMN gives hyperreflexia and spasticity, not fasciculations.
• Assuming all third nerve palsies with pupil involvement are ischaemic—pupil-involved suggests compression until proven otherwise.
• Mixing up anterior and posterior spinal artery syndromes: anterior spares dorsal columns (vibration/proprioception), posterior spares motor and pain/temperature.
• Using carbamazepine for absence seizures—it can exacerbate them; ethosuximide is first-line.
• Forgetting that in lateral medullary syndrome (Wallenberg), ipsilateral Horner's, ataxia, and facial pain occur with contralateral body pain/temperature loss.
• Thinking that all multiple sclerosis relapses require steroids—mild sensory symptoms without functional impairment may be observed.

How to Revise Neuroscience for the USMLE Step 1

Prioritise lesion localisation: draw the spinal cord and brainstem cross-sections to map tracts (corticospinal, spinothalamic, dorsal columns). Practise stroke syndromes by artery and lacunar syndromes (pure motor, pure sensory, ataxic hemiparesis). Memorise first-line antiepileptic drugs by seizure type and acute migraine protocols. Focus on cranial nerve exams: know the exit foramina and nuclear vs. fascicular vs. nerve lesions. Questions often present a brief vignette with a single localising sign (e.g., ptosis, mydriasis) and ask for the lesion site or causative drug. Use neuroanatomy atlases and sketch pathways repeatedly. Do not waste time on rare neurogenetic syndromes; stick to common presentations of stroke, MS, Parkinson's, and epilepsy.

Practise it: MedLumen has 30 Neuroscience questions for the USMLE Step 1, each with a full explanation and references.